IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Hikari Power Ltd

Q2 2019 Holdings

Filed 2019-08-08 | 115 holdings | $19.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Linde Public Limited Company(LIN)COMG5494J103$30.3K151,0200.2%
Danaher Corp(DHR)COM235851102$30.8K215,8000.2%
Allergan PLCSPONSORED ADRG0177J108$32.8K195,7000.2%
3M Co(MMM)COM88579Y101$33.6K193,6000.2%
Johnson & Johnson(JNJ)COM478160104$43.7K313,6100.2%
Wells Fargo & Co(WFC)COM949746101$68.4K1,445,8400.4%
Corcept Therapeutics Inc(CORT)COM218352102$187.0K16,7901.0%
Berkshire Hathaway Inc Class A(BRK/A)CL A084670108$237.2K7451.2%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$267.0K44,5201.4%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$486.0K130,0002.5%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$495.0K18,5352.6%
Anavex Life Sciences Corp(AVXL)COM032797300$587.0K174,0803.0%
Biogen Inc(BIIB)COM09062X103$3.3M14,13017.1%
Cisco Systems Inc(CSCO)COM17275R102$5.7M103,90029.4%
Deutsche X-Trackers Harvest CSI 300 China A-Shares Fund(ASHR)ETF233051879$7.4M263,04038.3%
PreviousPage 3 of 3